SRH Advisors’s Biogen BIIB Stock Holding History

SRH Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-39	Closed	-$9K	–	274
2019 Q1	$9K	Hold	39	–	–	0.03%	160
2018 Q4	$12K	Hold	39	–	–	0.05%	141
2018 Q3	$14K	Hold	39	–	–	0.05%	150
2018 Q2	$11K	Buy	+39	New	+$11K	0.04%	154

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SRH Advisors's BIIB Position: Q2 2019 in Review

SRH Advisors sold out of Biogen (BIIB) in Q2 2019, closing a stake of 39 shares — an estimated $9K sold.

SRH Advisors first reported a position in BIIB in Q2 2018 and held it in 4 quarters. The position peaked at $14K in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

SRH Advisors reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
SRH Advisors sold 39 Biogen shares in Q2 2019, an estimated $9K.
SRH Advisors first reported a position in Biogen in Q2 2018 and held it in 4 quarters.
SRH Advisors's Biogen position peaked at $14K in Q3 2018.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on SRH Advisors's 13F filing for Q2 2019, filed 26 Jul 2019.